Back

Primary prevention in systolic dysfunction/heart failure patients: use, misuse, and underuse

23 April 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Sudden death prevention and ICD therapy: unsolved issues Prevention EHRA Premium Access EHRA 2021

About the speaker

Photo
Associate Professor Markus Zabel

University Medical Centre of Gottingen (UMG), Goettingen (Germany)

4 More presentations in this session

Presentation thumbnail
Antitachycardia pacing and VT termination: fact or fancy? What is the impact on shock reduction from a patient's perspective?
Doctor U. Birgersdotter-Green (La Jolla, US)
Slides Video
Presentation thumbnail
No more therapy delivery after ventricular tachycardia ablation? Will my patient fear shock again?
Doctor A. Berruezo Sanchez (Barcelona, ES)
Slides Video
Presentation thumbnail
Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-MI patients with ejection fraction over 40% at SCD risk, insights from the PRESERVE EF study
Doctor K. Trachanas (Athens, GR)
Slides Video
Presentation thumbnail
Sudden death prevention and ICD therapy: unsolved issues - discussion

Access the full session

Session thumbnail
Sudden death prevention and ICD therapy: unsolved issues

The Event

Event poster

EHRA 2021

23 April - 25 April 2021
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Webinar
The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines
thumbnail
Congress Session
The storm will pass…

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources